<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-cells-08-00711">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Graef</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Moesta</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Norman</surname>
    <given-names>P.J.</given-names>
   </name>
   <name>
    <surname>Abi-Rached</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Vago</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Older Aguilar</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Gleimer</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hammond</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Guethlein</surname>
    <given-names>L.A.</given-names>
   </name>
   <name>
    <surname>Bushnell</surname>
    <given-names>D.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C</article-title>
  <source>J. Exp. Med.</source>
  <year>2009</year>
  <volume>206</volume>
  <fpage>2557</fpage>
  <lpage>2572</lpage>
  <pub-id pub-id-type="doi">10.1084/jem.20091010</pub-id>
  <?supplied-pmid 19858347?>
  <pub-id pub-id-type="pmid">19858347</pub-id>
 </element-citation>
</ref>
